Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole

We retrospectively assessed breakthrough invasive fungal infections (b-IFIs) in 100 consecutive patients with leukemia receiving single-agent isavuconazole; 13 had documented b-IFIs (candidiasis in 6, mucormycosis in 4). All b-IFIs were observed in patients with prolonged neutropenia and active leuk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Infect Dis
Hauptverfasser: Rausch, Caitlin R, DiPippo, Adam J, Bose, Prithviraj, Kontoyiannis, Dimitrios P
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2018
Schlagworte:
Brief Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6454429/
https://ncbi.nlm.nih.gov/pubmed/29771293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy406
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge